Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth-Reference-Cited by-同舟云学术

Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth

Published:2016-07-01 Issue: Volume: Page:now106
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Hashizume Rintaro,Zhang Ali,Mueller Sabine,Prados Michael D.,Lulla Rishi R.,Goldman Stewart,Saratsis Amanda M.,Mazar Andrew P.,Stegh Alexander H.,Cheng Shi-Yuan,Horbinski Craig,Haas-Kogan Daphne A.,Sarkaria Jann N.,Waldman Todd,James C. David

Funder

The Childhood Brain Tumor Foundation

NIH

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/11/1519/17431003/now106.pdf

Reference32 articles.

1. Specific inhibition of cyclin-dependent kinase 4/6 by PD-0332991 and associated antitumor activity in human tumor xenografts;Fry;Mol Cancer Ther,2004

2. Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6

3. A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6

4. Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models

5. Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway;Translational Oncology;2024-11

2. A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors;Neuro-Oncology;2024-07-09

3. BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma;Journal of Clinical Investigation;2024-05-21

4. CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer;Translational Lung Cancer Research;2024-05

5. DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology;Neuro-Oncology;2024-03-22